The biotech sponsor needed to demonstrate the safety and tolerability of the lead molecule in healthy volunteers, as well as direct target engagement and biomarker effects for IPF patients in a short space of time.
Who We Are
Our Services
Clinical Trial Management Services
Central Laboratory Services
Clinical Pharmacology
Scintigraphy
Pharmacovigilance
Regulatory Affairs
Clinical & Medical Writing
Clinical Trial Management Services
Phase I
Phase II
Phase III
Site Management & Monitoring
IMP Management
Biometric Services
The biotech sponsor needed to demonstrate the safety and tolerability of the lead molecule in healthy volunteers, as well as direct target engagement and biomarker effects for IPF patients in a short space of time.